Forian Inc. (FORA)
NASDAQ: FORA · Real-Time Price · USD
2.150
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Company Description
Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries.
It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.
The company’s subscription and services-based solutions cover the life sciences, pharmaceutical services, healthcare payer, and provider and financial services industries.
Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.
Forian Inc.
| Country | United States |
| Founded | 2014 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 50 |
| CEO | Max Wygod |
Contact Details
Address: 41 University Drive, Suite 400 Newtown, Pennsylvania 18940 United States | |
| Phone | 267 225 6263 |
| Website | forian.com |
Stock Details
| Ticker Symbol | FORA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001829280 |
| CUSIP Number | 34630N106 |
| ISIN Number | US34630N1063 |
| Employer ID | 85-3467693 |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Max C. Wygod | Co-Founder, Chief Executive Officer, President and Executive Chairman of the Board |
| Michael Vesey C.P.A. | Chief Financial Officer |
| Adam H. Dublin | Co-Founder, Chief Strategy Officer and Director |
| Caroline Strickland Mcgrail | General Counsel and Secretary |
| Jason Holden | Vice President of Corporate Development |
| Paul Reuscher | Chief Commercial Officer |
| Jeff Forringer | President of Kyber Data Science |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 16, 2026 | SC 13E3 | Going private transaction by certain issuers |
| Apr 16, 2026 | SC 14D9 | Filing |
| Apr 16, 2026 | SC 13E3 | Going private transaction by certain issuers |
| Apr 15, 2026 | SCHEDULE 13D/A | Filing |
| Apr 15, 2026 | SCHEDULE 13D/A | Filing |
| Apr 9, 2026 | SC TO-C | Filing |
| Apr 6, 2026 | SCHEDULE 13D/A | Filing |
| Apr 6, 2026 | SCHEDULE 13D/A | Filing |
| Apr 3, 2026 | 8-K | Current Report |
| Mar 27, 2026 | 10-K | Annual Report |